Autres langues BenevolentAI

Actions

BAI

LU2355630455

Marché Fermé - Euronext Amsterdam Autres places de cotation 17:35:03 09/05/2024			Varia. 5j.	Varia. 1 janv.
0,56 ^EUR	0,00%		-12,50%	-48,15%

02/05	Benevolentai S.A. annonce des changements de direction	CI
15/04	BenevolentAI S.A. annonce la démission de membres de son conseil d'administration, avec effet au 2 mai 2024	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

BenevolentAI - Result of Annual General Meeting	03/05
BenevolentAI : Benevolent AI, - Result of Annual General Meeting	02/05
BenevolentAI: Result of Annual General Meeting	02/05
Benevolentai S.A. Announces Directorate Changes	02/05
BenevolentAI : Major shareholding notifications Major shareholding notification	01/05
BenevolentAI : Benevolent AI, - BenevolentAI provides an update on its business priorities	23/04
BenevolentAI Provides an Update on Its Business Priorities	23/04
BenevolentAI - Publication of the Revised Agenda for the 2024 AGM	18/04
BenevolentAI : Benevolent AI, - Publication of the Revised Agenda for the 2024 AGM	17/04
BenevolentAI : Inside Information / Ad Hoc Information Publication of the Revised Agenda for the 2024 AGM	17/04
BenevolentAI: Publication of the Revised Agenda for the 2024 AGM	17/04
Proposed changes to BenevolentAI's Board composition	16/04
Proposed Changes to BenevolentAI’s Board Composition	15/04
BenevolentAI S.A. Announces Board Resignations, Effective from May 2, 2024	15/04
BenevolentAI Founder Reportedly Calls for Board Revamp	03/04
BenevolentAI Founder Reportedly Calls for Board Revamp	02/04
Kenneth Mulvany Sends a Letter to Benovelent AI	02/04
EARNINGS: EPE Special "cautiously optimistic"; RTW Biotech NAV rises	02/04
BenevolentAI : Inside Information / Ad Hoc Information BenevolentAI announces positive topline safety and pharmacokinetic data from the Phase Ia clinical study of BEN-8744 in healthy volunteers	25/03
BenevolentAI Announces Positive Topline Safety and Pharmacokinetic Data from the Phase Ia Clinical Study of BEN-8744 in Healthy Volunteers	25/03

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues BenevolentAI

Actions

BAI

LU2355630455

Autres langues

Filtres